Literature DB >> 27612156

Pathogenesis and Molecular Mechanisms of Zika Virus.

Shriddha Nayak1, Jun Lei1, Andrew Pekosz2, Sabra Klein2, Irina Burd1.   

Abstract

Zika virus (ZIKV) is one of the most important emerging viruses of 2016. A developing outbreak in the Americas has demonstrated an association between the virus and serious clinical manifestations, such as Guillain-Barré syndrome in adults and congenital malformations in infants born to infected mothers. Pathogenesis and mechanisms of neurologic or immune disease by ZIKV have not been clearly delineated. However, several pathways have been described to explain viral involvement in brain and immune system as well as other organ systems such as eye, skin, and male and female reproductive tracts. ZIKV activates toll-like receptor 3 and several pathways have been described to explain the mechanisms at a molecular level. The mechanism of microcephaly has been more difficult to demonstrate experimentally, likely due to the multifactorial and complex nature of the phenotype. This article provides an overview of existing literature on ZIKV pathogenicity and possible molecular mechanisms of disease as outlined to date. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27612156     DOI: 10.1055/s-0036-1592071

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  6 in total

Review 1.  Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.

Authors:  Tiffany A Peterson; Andrew G MacLean
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-13       Impact factor: 4.147

2.  Suggested mechanisms for Zika virus causing microcephaly: what do the genomes tell us?

Authors:  Se-Ran Jun; Trudy M Wassenaar; Visanu Wanchai; Preecha Patumcharoenpol; Intawat Nookaew; David W Ussery
Journal:  BMC Bioinformatics       Date:  2017-12-28       Impact factor: 3.169

3.  Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid.

Authors:  Jun-Gyu Park; Ginés Ávila-Pérez; Ferralita Madere; Thomas A Hilimire; Aitor Nogales; Fernando Almazán; Luis Martínez-Sobrido
Journal:  Front Microbiol       Date:  2019-04-12       Impact factor: 5.640

Review 4.  Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.

Authors:  Philip Kiely; Manoj Gambhir; Allen C Cheng; Zoe K McQuilten; Clive R Seed; Erica M Wood
Journal:  Transfus Med Rev       Date:  2017-05-15

5.  The Antiviral Drug Arbidol Inhibits Zika Virus.

Authors:  Susan L Fink; Lucia Vojtech; Jessica Wagoner; Natalie S J Slivinski; Konner J Jackson; Ruofan Wang; Sudip Khadka; Priya Luthra; Christopher F Basler; Stephen J Polyak
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

Review 6.  Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development.

Authors:  Jacob T Beaver; Nadia Lelutiu; Rumi Habib; Ioanna Skountzou
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.